NCT07371208 2026-01-27ST-A-TNShanghai Jiao Tong University School of MedicinePhase 2 Recruiting40 enrolled
NCT07179783 2025-09-18Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)Tianjin Medical University Second HospitalPhase 2 Recruiting28 enrolled